FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/12/077754 [Registered on: 06/12/2024] Trial Registered Prospectively
Last Modified On: 02/12/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   To study efficacy of Simhasyadi kwatha in management of Hyperuricemia. 
Scientific Title of Study   A clinical study of the effect of Simhasyadi kwatha in the management of Hyperuricemia. 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Aditi Acharya  
Designation  PG scholar  
Affiliation  Govt Ayurvedic College and Hospital Guwahati  
Address  Govt. Ayurvedic College and Hospital, Guwahati-14

Kamrup
ASSAM
781014
India 
Phone  9395876468  
Fax    
Email  dr.acharya.aditi271999@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Prof Dr Pranabjyoti Baishya  
Designation  Principal i/c cum Professor , Govt Ayurvedic College Guwahati (Guide) 
Affiliation  Govt Ayurvedic College and Hospital Guwahati  
Address  Govt Ayurvedic College and Hospital Guwahati

Kamrup
ASSAM
781014
India 
Phone  8638019124  
Fax    
Email  drpjbaishya1967@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Manir Uddin Dewan  
Designation  Assistant Professor, Dept of Kayachikitsa (co-guide)  
Affiliation  Govt Ayurvedic college and hospital Guwahati  
Address  Govt Ayurvedic College and Hospital Guwahati

Kamrup
ASSAM
781014
India 
Phone  9864174788  
Fax    
Email  dr.manir@gmail.com  
 
Source of Monetary or Material Support  
Govt Ayurvedic college and hospital Guwahati.781014 
 
Primary Sponsor  
Name  Dr Aditi Acharya  
Address  Govt Ayurvedic college and hospital Guwahati, 781014 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Aditi Acharya   Govt Ayurvedic college and hospital Guwahati -14  OPD and IPD of Dept of Kayachikitsa, Govt Ayurvedic College and Hospital Guwahati -14
Kamrup
ASSAM 
9395876468

dr.acharya.aditi271999@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee, Govt Ayurvedic College and Hospital Guwahati -14  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:E790||Hyperuricemia without signs of inflammatory arthritis and tophaceous disease. Ayurveda Condition: VATARAKTAM,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator Arm (Non Ayurveda)-Febuxostat 40mg Tab Febuxostat 40mg once daily after food
2Intervention ArmDrugClassical(1) Medicine Name: Simhasyadi kwatha , Reference: Bhavaprakasha Vatarakta chikitsa prakaran 29/50-51, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 50(ml), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 60 Days, anupAna/sahapAna: No, Additional Information:
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  1.Patients of both the sex and age between 20-70 years.2.Naive patients or newly diagnosed patients of Hyperuricemia.3.Patients having serum uric acid more than 6.9mg/dl.4. Patients of Hyperuricemia with Gouty Arthritis.5.Patient recently diagnosed with uncomplicated Hyperuricemia & Gouty Arthritis.6.Hyperuricemic patients suffering from controlled hypertension, diabetes mellitus, CKD upto stage 3. 
 
ExclusionCriteria 
Details  1.Asymptomatic patient with Hyperuricemia. 2.Patients suffering from the complications of Hyperuricemia & Gouty Arthritis. 3.Pregnant and lactating women. 4.Presence of disease like CA, HIV, malignant hypertension, uncontrolled diabetes. 5. Patients suffering from major systemic illness or under long term drug treatment. 6.History of hypersensitivity to any of the trial drugs or their ingredients. 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Other 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To asses the effectiveness of SIMHASYADI KWATHA in management of symptomatology of Hyperuricemia.  45 days 
 
Secondary Outcome  
Outcome  TimePoints 
To compare the effect of SIMHASYADI KWATHA and FEBUXOSTAT on serum uric acid level parameter.  30, 45 and 60 days  
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   17/12/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is a clinical study of SIMHASYADI KWATHA in management of Hyperuricemia. This study is done as a mandatory Post graduation thesis work. Total number of 60 patients will be studied for 60 days each. 
Close